|
GINS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23976392987879E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02869999582833E-08 |
| Normal-vs-Stage2 |
4.762900E-03 |
| Normal-vs-Stage3 |
3.5723000002541E-07 |
| Normal-vs-Stage4 |
2.116000E-02 |
| Stage1-vs-Stage2 |
8.523000E-01 |
| Stage1-vs-Stage3 |
1.839850E-03 |
| Stage1-vs-Stage4 |
6.332600E-01 |
| Stage2-vs-Stage3 |
1.984020E-02 |
| Stage2-vs-Stage4 |
7.811000E-01 |
| Stage3-vs-Stage4 |
1.078560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.90765197977316E-12 |
| Normal-vs-AfricanAmerican |
1.50174999999919E-05 |
| Normal-vs-Asian |
7.982400E-02 |
| Caucasian-vs-AfricanAmerican |
5.749700E-02 |
| Caucasian-vs-Asian |
2.389800E-01 |
| AfricanAmerican-vs-Asian |
2.862000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31940014469478E-10 |
| Normal-vs-Female |
8.30530089146464E-11 |
| Male-vs-Female |
1.674380E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.56430000003627E-06 |
| Normal-vs-Extreme_Weight |
1.14439999998606E-06 |
| Normal-vs-Obese |
8.08169975385908E-10 |
| Normal-vs-Extreme_Obese |
2.670000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.330400E-01 |
| Normal_Weight-vs-Obese |
3.484300E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.215960E-01 |
| Extreme_Weight-vs-Obese |
8.156800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.112600E-01 |
| Obese-vs-Extreme_Obese |
2.505900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.648000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.74416037168612E-13 |
| Normal-vs-Age(61-80Yrs) |
1.89509999914961E-08 |
| Normal-vs-Age(81-100Yrs) |
1.133410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.851220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.219900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.264400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.083800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.809000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.979730E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.5408009030059E-11 |
| Normal-VS-Type2 PRCC |
8.16430000000201E-05 |
| Normal-VS-KIRP CIMP |
3.043000E-03 |
| Normal-VS-Unclassified PRCC |
1.71667999999681E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.668400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.389700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.421200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.544580E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.542990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.760100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08979999999359E-05 |
| Normal-vs-N1 |
4.27479999998148E-06 |
| Normal-vs-N2 |
3.453200E-01 |
| N0-vs-N1 |
6.696600E-03 |
| N0-vs-N2 |
9.604400E-01 |
| N1-vs-N2 |
3.011000E-01 |
|
|
